This research explores how alcohol consumption disrupts metabolism, damages the liver, and impairs male reproductive health, emphasizing the complex mechanisms and public health implications.
Gilead, Arcus’ PhII gastroesophageal cancer data argue for TIGIT antibody drug class potential
Gilead and partner Arcus Biosciences’ anti-TIGIT-based regimen has shown early signs of efficacy in a small group of gastroesophageal cancer patients in a mid-stage trial,